Why Generic Drug Manufacturing Is Faltering And Ways To Bolster It

Academic expert provides insight into the economic and quality challenges behind generic drug shortages, and what to do about it.

It is time for the federal sector to help resolve growing US drug shortages by looking for more creative approaches to make the generic drug sector more viable, argues a professor and senior research advisor with Washington University’s Olin Business School who leads a non-profit initiative launched by the state of Missouri to help solve the problem.

Various economic depict show how severely the sector’s economic viability has declined over the past five or 10 years, Anthony...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Generics

More from Biosimilars & Generics